GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deccan Health Care Ltd (BOM:542248) » Definitions » YoY EBITDA Growth

Deccan Health Care (BOM:542248) YoY EBITDA Growth : 111.36% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Deccan Health Care YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Deccan Health Care's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 111.36%.

Deccan Health Care's EBITDA per Share for the six months ended in Mar. 2024 was ₹1.02.

Deccan Health Care YoY EBITDA Growth Historical Data

The historical data trend for Deccan Health Care's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deccan Health Care YoY EBITDA Growth Chart

Deccan Health Care Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only -37.84 -82.36 7.55 10.13 29.92

Deccan Health Care Semi-Annual Data
Mar16 Mar17 Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -103.50 -44.18 379.77 26.34 111.36

Deccan Health Care YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Deccan Health Care's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(2.019-1.554)/ | 1.554 |
=29.92 %

Deccan Health Care's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(1.023-0.484)/ | 0.484 |
=111.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deccan Health Care YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Deccan Health Care's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Deccan Health Care (BOM:542248) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deccan Health Care Ltd (BOM:542248) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:524711 BOM:524703 BOM:530317 BOM:506919 BOM:530233 BOM:537253 BOM:542678 NSE:JFLLIFE BOM:524202 BOM:524396 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
H.No. 6-3-348/4, Dwarakapuri Colony, Punjagutta, Hyderabad, TG, IND, 500082
Website
https://www.deccanhealthcare.co.in
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products including nutraceutical, cosmeceutical, and ayurveda products ( Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company operates in India as well as exports its products to other countries and the maximum of its revenue comes from India.

Deccan Health Care (BOM:542248) Headlines

No Headlines